The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
„Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype
Abstract
In the spleens of young, adult mice there exist naturally occurring killer lymphocytes with specificity for mouse Moloney leukemia cells. The lytic activity was directed against syngeneic or allogeneic Moloney leukemia cells to a similar extent, but was primarily expressed when tested against in vitro grown leukemia cells. Two leukemias of non‐Moloney origin were resistant and so was the mastocytoma line P815. Although killer activity varied between different strains of mice, the specificity of lysis was the same as indicated by competition experiments using unlabeled Moloney or other tumor cells as inhibitors in the cytotoxic assays. Capacity to compete and sensitivy to lysis by the killer cells were found to be highly positively correlated. Analysis of the kinetics of the cytotoxic assay revealed a rapid induction of lysis within one to four hours, arguing against any conventional in vitro induction of immune response. No evidence was found of soluble factors playing any role in the cytolytic assay.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kiessling, R., Klein, E., Pross, H., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050209 · Cited by 1,143
Self-citationReactivity of lymphocytes from normal persons on cultured tumor cells.
Takasugi, M., Mickey, M. R., & Terasaki, P. I. (1973) · PubMed · Cited by 433
Rosenberg, E. B., McCoy, J. L., Green, S. S., Donnelly, F. C., Siwarski, D. F., Levine, P. H., & Herberman, R. B. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/52.2.345 · Cited by 186
NATURAL KILLER CELLS IN THE MOUSE
Kiessling, R. W. (1976) · Elsevier eBooks · doi:10.1016/b978-0-12-401660-6.50012-6 · Cited by 173
Self-citationHL-A 3,7 AND LYMPHOCYTE CYTOTOXIC ACTIVITY
Petrányi, G., Benczur, M., Ónody, C., Hollan, S. R., & Ivanyi, P. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92943-2 · Cited by 45
Cited by
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Innate or adaptive immunity? The example of natural killer cells
Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S. (2011) · Science · doi:10.1126/science.1198687 · Cited by 2,824
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687
Zinkernagel, R. M., & Doherty, P. C. (1979) · Advances in Immunology · doi:10.1016/s0065-2776(08)60262-x · Cited by 1,933
Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ Genes
Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., & Stewart, T. A. (1993) · Science · doi:10.1126/science.8456300 · Cited by 1,727
The biology of innate lymphoid cells
Artis, D., & Spits, H. (2015) · Nature · doi:10.1038/nature14189 · Cited by 1,634
CD107a as a functional marker for the identification of natural killer cell activity
Alter, G., Malenfant, J. M., & Altfeld, M. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.08.008 · Cited by 1,410
Herberman, R. B., Nunn, M. E., & Lavrin, D. H. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910160204 · Cited by 1,355
Natural Killer Cells: Their Roles in Defenses Against Disease
Herberman, R. B., & Ortaldo, J. R. (1981) · Science · doi:10.1126/science.7025208 · Cited by 1,336
Exploring the NK cell platform for cancer immunotherapy
Myers, J. A., & Miller, J. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0426-7 · Cited by 1,276
NK cells for cancer immunotherapy
Shimasaki, N., Jain, A., & Campana, D. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0052-1 · Cited by 1,222
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Abel, A. M., Yang, C., Thakar, M. S., & Malarkannan, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01869 · Cited by 1,150
Kiessling, R., Klein, E., Pross, H., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050209 · Cited by 1,143
Self-citationNatural Cell-Mediated Immunity
(1978) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60936-7 · Cited by 1,053
Lugade, A. A., Moran, J. P., Gerber, S. A., Rose, R. C., Frelinger, J. G., & Lord, E. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7516 · Cited by 966
“The Yac-1 line, which is sensitive to NK cell-mediated lysis, was used to detect these cells within our TIL preparations (22).”
BackgroundMethodDendritic Cells Prime Natural Killer Cells by trans-Presenting Interleukin 15
Lucas, M., Schachterle, W., Oberle, K., Aichele, P., & Diefenbach, A. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.006 · Cited by 887
RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., & Moretta, L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.619 · Cited by 875
Targeting natural killer cells and natural killer T cells in cancer
Vivier, E., Ugolini, S., Blaise, D., Chabannon, C., & Brossay, L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3174 · Cited by 850
CAR-NK cells: A promising cellular immunotherapy for cancer
Xie, G., Dong, H., Liang, Y., Ham, J. D., Rizwan, R., & Chen, J. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102975 · Cited by 800
“[2,3] Since then, they are shown to exhibit potent anti-tumour immunity through multiple mechanisms.”
BackgroundEnhanced NK cell activity in mice injected with interferon and interferon inducers
GIDLUND, M., ÖRN, A., WIGZELL, H., SENIK, A., & GRESSER, I. (1978) · Nature · doi:10.1038/273759a0 · Cited by 734
Self-citationTrinchieri, G., & Santoli, D. (1978) · The Journal of experimental medicine · doi:10.1084/jem.147.5.1314 · Cited by 733
NK cell-based cancer immunotherapy: from basic biology to clinical development
Liu, S., Galat, V., Galat4, Y., Lee, Y. K. A., Wainwright, D., & Wu, J. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-01014-w · Cited by 689
NK cell development, homeostasis and function: parallels with CD8+ T cells
Sun, J. C., & Lanier, L. L. (2011) · Nature Reviews Immunology · doi:10.1038/nri3044 · Cited by 700
NK cells and cancer immunosurveillance
Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682
NK cell-based immunotherapy for malignant diseases
Cheng, M., Chen, Y., Xiao, W., Sun, R., & Tian, Z. (2013) · Cellular & Molecular Immunology · doi:10.1038/cmi.2013.10 · Cited by 631
Marcus, A., Mao, A. J., Lensink-Vasan, M., Wang, L., Vance, R. E., & Raulet, D. H. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.016 · Cited by 611
Self-tolerance of natural killer cells
Raulet, D. H., & Vance, R. E. (2006) · Nature Reviews Immunology · doi:10.1038/nri1863 · Cited by 608
Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
Fujisaki, H., Kakuda, H., Shimasaki, N., Imai, C., Ma, J., Lockey, T., Eldridge, P., Leung, W. H., & Campana, D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3712 · Cited by 595
Genetic and Environmental Determinants of Human NK Cell Diversity Revealed by Mass Cytometry
Horowitz, A., Strauss-Albee, D. M., Leipold, M., Kubo, J., Nemat-Gorgani, N., Dogan, O. C., Dekker, C. L., Mackey, S., Maecker, H., Swan, G. E., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006702 · Cited by 592
Natural killer cell memory in infection, inflammation and cancer
Cerwenka, A., & Lanier, L. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.9 · Cited by 576
The Virology and Immunobiology of Lymphocytic Choriomeningitis Virus Infection
Buchmeier, M. J., Welsh, R. M., Dutko, F. J., & Oldstone, M. B. A. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60197-2 · Cited by 545
Prospects for the use of NK cells in immunotherapy of human cancer
Ljunggren, H.-G., & Malmberg, K.-J. (2007) · Nature Reviews Immunology · doi:10.1038/nri2073 · Cited by 543
A glycolipid on the surface of mouse natural killer cells
Kasai, M., Iwamod, M., Nagai, Y., Okumura, K., & Tada, T. (1980) · European Journal of Immunology · doi:10.1002/eji.1830100304 · Cited by 535
Role of NK cells in tumour growth and metastasis in beige mice
Talmadge, J. E., Meyers, K. M., Prieur, D. J., & Starkey, J. R. (1980) · Nature · doi:10.1038/284622a0 · Cited by 527
Influence of Resveratrol on the Immune Response
Malaguarnera, L. (2019) · Nutrients · doi:10.3390/nu11050946 · Cited by 526
Regulation of the Natural Killer Cell Receptor Repertoire
Raulet, D. H., Vance, R. E., & McMahon, C. W. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.291 · Cited by 521
Natural killer cells in antiviral immunity
Björkström, N. K., Strunz, B., & Ljunggren, H.-G. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00558-3 · Cited by 503
Tumor-Infiltrating Natural Killer Cells
Cózar, B., Greppi, M., Carpentier, S., Narni-Mancinelli, E., Chiossone, L., & Vivier, E. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0655 · Cited by 476
Kopp, H.-G., Placke, T., & Salih, H. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2123 · Cited by 469
Vivier, E., Rebuffet, L., Narni-Mancinelli, E., Cornen, S., Igarashi, R. Y., & Fantin, V. R. (2024) · Nature · doi:10.1038/s41586-023-06945-1 · Cited by 467
Kiessling, R., Hochman, P. S., Haller, O., Shearer, G. M., Wigzell, H., & Cudkowicz, G. (1977) · European Journal of Immunology · doi:10.1002/eji.1830070915 · Cited by 460
Self-citationThe Intriguing History of Cancer Immunotherapy
Dobosz, P., & Dzieciątkowski, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02965 · Cited by 458
Uterine NK cells: active regulators at the maternal-fetal interface
Moffett, A., & Colucci, F. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68107 · Cited by 453
Colorectal Cancer Immunotherapy: Options and Strategies
Johdi, N. A., & Sukor, N. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01624 · Cited by 452
Emerging insights into natural killer cells in human peripheral tissues
Björkström, N. K., Ljunggren, H.-G., & Michaëlsson, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.34 · Cited by 449
NATURAL KILLER CELL DEVELOPMENTAL PATHWAYS: A Question of Balance
Di Santo, J. P. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090700 · Cited by 448
Natural Killer Cells and Cancer
(2003) · Advances in Cancer Research · doi:10.1016/s0065-230x(03)90004-2 · Cited by 438
Regulation of short-chain fatty acids in the immune system
Liu, X.-F., Shao, J.-H., Liao, Y.-T., Wang, L.-N., Jia, Y., Dong, P.-J., Liu, Z.-Z., He, D.-D., Li, C., & Zhang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186892 · Cited by 403
The Natural Cytotoxicity Receptors in Health and Disease
Barrow, A. D., Martin, C. J., & Colonna, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00909 · Cited by 370
Yang, L., Chu, Z., Liu, M., Zou, Q., Li, J., Liu, Q., Wang, Y., Wang, T., Xiang, J., & Wang, B. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01453-1 · Cited by 352
Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M. C., & Moretta, L. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00943.x · Cited by 350
An Analysis of the Murine NK Cell as to Structure, Function and Biological Relevance
Kiessling, R., & Wigzell, H. (1979) · Immunological Reviews · doi:10.1111/j.1600-065x.1979.tb00270.x · Cited by 350
Self-citationBi, J., & Tian, Z. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00760 · Cited by 325
NK Cells, MHC Class I Molecules and the Missing Self
Kärre, K. (2002) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2002.01053.x · Cited by 325
NK cell-based immunotherapy for cancer
Fang, F., Xiao, W., & Tian, Z. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.07.009 · Cited by 306
Natural killer cell-mediated immunosurveillance of human cancer
Malmberg, K.-J., Carlsten, M., Björklund, A., Sohlberg, E., Bryceson, Y. T., & Ljunggren, H.-G. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.002 · Cited by 299
Natural killer cell recognition of missing self
Kärre, K. (2008) · Nature Immunology · doi:10.1038/ni0508-477 · Cited by 296
Welsh, J. R. (1978) · The Journal of Experimental Medicine · doi:10.1084/jem.148.1.163 · Cited by 293
Joncker, N. T., Fernandez, N. C., Treiner, E., Vivier, E., & Raulet, D. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803900 · Cited by 291
Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease
Nielsen, C. M., White, M. J., Goodier, M. R., & Riley, E. M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00422 · Cited by 282
The role of cytokines in the regulation of NK cells in the tumor environment
Konjević, G. M., Vuletić, A. M., Mirjačić Martinović, K. M., Larsen, A. K., & Jurišić, V. B. (2019) · Cytokine · doi:10.1016/j.cyto.2019.02.001 · Cited by 279
Natural cytotoxicity receptors and their ligands
Kruse, P. H., Matta, J., Ugolini, S., & Vivier, E. (2014) · Immunology & Cell Biology · doi:10.1038/icb.2013.98 · Cited by 273
Developmental and Functional Control of Natural Killer Cells by Cytokines
Wu, Y., Tian, Z., & Wei, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00930 · Cited by 269
Impaired immune responses in the lungs of aged mice following influenza infection
Toapanta, F. R., & Ross, T. M. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-112 · Cited by 259
Cell Therapy: Types, Regulation, and Clinical Benefits
El-Kadiry, A. E.-H., Rafei, M., & Shammaa, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.756029 · Cited by 256
“Immunophenotypically, NK cells are CD3CD56 (137, 142).”
Rodewald, H.-R., Moingeon, P., Lucich, J. L., Dosiou, C., Lopez, P., & Reinherz, E. L. (1992) · Cell · doi:10.1016/0092-8674(92)90125-v · Cited by 255
Carlsten, M., Björkström, N. K., Norell, H., Bryceson, Y., van Hall, T., Baumann, B. C., Hanson, M., Schedvins, K., Kiessling, R., Ljunggren, H.-G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2264 · Cited by 234
Self-citationCAR-NK for tumor immunotherapy: Clinical transformation and future prospects
Wang, W., Jiang, J., & Wu, C. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.11.033 · Cited by 221
Innate Lymphoid Cell Development: A T Cell Perspective
Cherrier, D. E., Serafini, N., & Di Santo, J. P. (2018) · Immunity · doi:10.1016/j.immuni.2018.05.010 · Cited by 181
IL-15 signaling in NK cell cancer immunotherapy
Rautela, J., & Huntington, N. D. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.10.004 · Cited by 125
Vliegen, I., Duijvestijn, A., Grauls, G., Herngreen, S., Bruggeman, C., & Stassen, F. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2003.09.024 · Cited by 80
The Host Defense Peptide Cathelicidin Is Required for NK Cell-Mediated Suppression of Tumor Growth
Büchau, A. S., Morizane, S., Trowbridge, J., Schauber, J., Kotol, P., Bui, J. D., & Gallo, R. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902110 · Cited by 73
Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease
Martínez-Chantar, M. L., Delgado, T. C., & Beraza, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640869 · Cited by 67
SCOTT, M. J., HOTH, J. J., STAGNER, M. K., GARDNER, S. A., PEYTON, J. C., & CHEADLE, W. G. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02547.x · Cited by 53
Larena, M., Regner, M., & Lobigs, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044834 · Cited by 38
Natural Killer Cell Activation Receptor NKp30 Oligomerization Depends on Its N-Glycosylation
Skořepa, O., Pazicky, S., Kalousková, B., Bláha, J., Abreu, C., Ječmen, T., Rosůlek, M., Fish, A., Sedivy, A., Harlos, K., et al. (2020) · Cancers · doi:10.3390/cancers12071998 · Cited by 21
Recent advances in our understanding of the allograft response
Hennessy, C., Lewik, G., Cross, A., Hester, J., & Issa, F. (2021) · Faculty Reviews · doi:10.12703/r/10-21 · Cited by 18
Metadata
- Authors
- Kiessling, R., Klein, E., & Wigzell, H.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1975-02
- Volume
- 5
- Issue
- 2
- Pages
- 112-117
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2129278872
- Cited by
- 1,824
- References
- 5
- FWCI
- 17.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.